|
1
|
Vogel B, Acevedo M, Appelman Y, Bairey
Merz CN, Chieffo A, Figtree GA, Guerrero M, Kunadian V, Lam CSP,
Maas AHEM, et al: The lancet women and cardiovascular disease
commission: Reducing the global burden by 2030. Lancet.
397:2385–2438. 2021.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Bhatt P, Parikh P, Patel A, Parikh R,
Patel A, Mehta JL and Parikh K: Unique aspects of coronary artery
disease in indian women. Cardiovasc Drugs Ther. 29:369–376.
2015.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Duda-Pyszny D, Trzeciak P and Gąsior M:
Coronary artery disease in women. Pol J Cardiothoracic Surg.
15:44–48. 2018.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Vijayalakshmi IB, Nemani L, Kher M and
Kumar A: The gamut of coronary artery disease in Indian women.
Indian J Cardiovasc Dis Women. 8:43–51. 2023.
|
|
5
|
Dell'Aversana F, Tedeschi C, Comune R,
Gallo L, Ferrandino G, Basco E, Tamburrini S, Sica G, Masala S,
Scaglione M and Liguori C: Advanced cardiac imaging and women's
chest pain: A question of gender. Diagnostics (Basel).
13(2611)2023.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Andersson C, Nayor M, Tsao CW, Levy D and
Vasan RS: Framingham heart study: JACC focus seminar, 1/8. J Am
Coll Cardiol. 77:2680–2692. 2021.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Li X, Tan Y, Liu B, Guo H, Zhou Y, Yuan J
and Wang F: Mitochondrial lipid metabolism genes as diagnostic and
prognostic indicators in hepatocellular carcinoma. Curr Genomics.
24:110–127. 2023.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Xu SY, Zhang QL, Zhang Q, Wan L, Jiang J,
Tu T, Manavis J, Pan A, Cai Y and Yan XX: Regional and cellular
mapping of sortilin immunoreactivity in adult human brain. Front
Neuroanat. 13(31)2019.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Kandror KV: The role of sortilin in the
‘Glut4 pathway’. Commun Integr Biol. 11(e1393592)2017.
|
|
10
|
Hermey G: The Vps10p-domain receptor
family. Cell Mol Life Sci. 66:2677–2689. 2009.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Petersen CM, Nielsen MS, Nykjær A,
Jacobsen L, Tommerup N, Rasmussen HH, Roigaard H, Gliemann J,
Madsen P and Moestrup SK: Molecular identification of a novel
candidate sorting receptor purified from human brain by
receptor-associated protein affinity chromatography. J Biol Chem.
272:3599–3605. 1997.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Mitok KA, Keller MP and Attie AD: Sorting
through the extensive and confusing roles of sortilin in metabolic
disease. J Lipid Res. 63(100243)2022.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Quistgaard EM, Madsen P, Grøftehauge MK,
Nissen P, Petersen CM and Thirup SS: Ligands bind to sortilin in
the tunnel of a ten-bladed beta-propeller domain. Nat Struct Mol
Biol. 16:96–98. 2009.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Malik AR and Willnow TE: VPS10P domain
receptors: Sorting out brain health and disease. Trends Neurosci.
43:870–885. 2020.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Nielsen MS, Madsen P, Christensen EI,
Nykjær A, Gliemann J, Kasper D, Pohlmann R and Petersen CM: The
sortilin cytoplasmic tail conveys Golgi-endosome transport and
binds the VHS domain of the GGA2 sorting protein. EMBO J.
20:2180–2190. 2001.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Expert Panel on Detection, Evaluation and
Treatment of High Blood Cholesterol in Adults. Executive summary of
the third report of the national cholesterol education program
(NCEP) expert panel on detection, evaluation, and treatment of high
blood cholesterol in adults (adult treatment panel III). JAMA.
285:2486–2497. 2001.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Lipsy RJ: The national cholesterol
education program adult treatment panel III guidelines. J Manag
Care Pharm. 9 (Suppl 1):S2–S5. 2003.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Pinxterhuis TH, Ploumen EH, Doggen CJM,
Hartmann M, Schotborgh CE, Anthonio RL, Roguin A, Danse PW, Benit
E, Aminian A, et al: First myocardial infarction in patients with
premature coronary artery disease: insights into patient
characteristics and outcome after treatment with contemporary
stents. Eur Heart J Acute Cardiovasc Care. 12:774–781.
2023.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Yokokawa H, Yasumura S, Tanno K, Ohsawa M,
Onoda T, Itai K, Sakata K, Kawamura K, Tanaka F, Yoshida Y, et al:
Serum low-density lipoprotein to high-density lipoprotein ratio as
a predictor of future acute myocardial infarction among men in a
2.7-year cohort study of a japanese northern rural population. J
Atheroscler Thromb. 18:89–98. 2011.PubMed/NCBI View
Article : Google Scholar
|
|
20
|
Savic L, Mrdovic I, Asanin M, Stankovic S,
Lasica R, Krljanac G, Simic D and Matic D: Long-term prognosis
after ST-elevation myocardial infarction in patients with premature
coronary artery disease. J Pers Med. 14(231)2024.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Jortveit J, Pripp AH, Langørgen J and
Halvorsen S: Incidence, risk factors and outcome of young patients
with myocardial infarction. Heart. 106:1420–1426. 2020.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Kallström A, Holopainen I, Kambur O,
Perola M, Salomaa V, Havulinna AS, Ramste M and Sinisalo J:
Divergent trends in the incidence and mortality of acute myocardial
ischaemic syndrome, especially in women. Evidence from Finland in
1996-2021. Ann Med. 56(2424455)2024.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Berger S, Raman G, Vishwanathan R, Jacques
PF and Johnson EJ: Dietary cholesterol and cardiovascular disease:
A systematic review and meta-analysis. Am J Clin Nutr. 102:276–294.
2015.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Raitakari O, Kivelä A, Pahkala K, Rovio S,
Mykkänen J, Ahola-Olli A, Loo BM, Lyytikäinen LP, Lehtimäki T,
Kähönen M, et al: Long-term tracking and population characteristics
of lipoprotein (a) in the cardiovascular risk in young Finns study.
Atherosclerosis. 356:18–27. 2022.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Gupta A, Wang Y, Spertus JA, Geda M,
Lorenze N, Nkonde-Price C, D'Onofrio G, Lichtman JH and Krumholz
HM: Trends in acute myocardial infarction in young patients and
differences by sex and race, 2001 to 2010. J Am Coll Cardiol.
64:337–345. 2014.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Khoja A, Andraweera PH, Lassi ZS, Ali A,
Zheng M, Pathirana MM, Aldridge E, Wittwer MR, Chaudhuri DD,
Tavella R and Arstall MA: Risk factors for premature coronary heart
disease in women compared to men: Systematic review and
meta-analysis. J Womens Health (Larchmt). 32:908–920.
2023.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Aggarwal A, Srivastava S and Velmurugan M:
Newer perspectives of coronary artery disease in young. World J
Cardiol. 8:728–734. 2016.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Berbach L, Nelsa Atongfor Nguéfack C,
Potter BJ, Pacheco C and Forcillo J: Prevalence of cardiovascular
risk factors in women with obstructive coronary disease requiring
revascularization: A meta-analysis. CJC Open. 6:334–346.
2023.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Hosseini K, Yavari N, Pashang M, Jalali A,
Nalini M, Majdi Nassab F, Sadeghian S, Salehi Omran A, Bagheri J,
Poorhosseini H, et al: Sex difference in the risk factor
distributions and outcomes after coronary artery bypass graft
surgery in the young population. Eur J Cardiothorac Surg.
62(ezab475)2022.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Poorzand H, Tsarouhas K, Hozhabrossadati
SA, Khorrampazhouh N, Bondarsahebi Y, Bacopoulou F, Rezaee R,
Jafarzadeh Esfehani R and Morovatdar N: Risk factors of premature
coronary artery disease in Iran: A systematic review and
meta-analysis. Eur J Clin Invest. 49(e13124)2019.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Madonna R, Balistreri CR, De Rosa S,
Muscoli S, Selvaggio S, Selvaggio G, Ferdinandy P and De Caterina
R: Impact of sex differences and diabetes on coronary
atherosclerosis and ischemic heart disease. J Clin Med.
8(98)2019.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Yang J, Biery DW, Singh A, Divakaran S,
DeFilippis EM, Wu WY, Klein J, Hainer J, Ramsis M, Natarajan P, et
al: Risk factors and outcomes of very young adults who experience
myocardial infarction: The partners YOUNG-MI registry. Am J Med.
133:605–612.e1. 2020.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Sun J, Zhou W, Gu T, Zhu D and Bi Y: A
retrospective study on association between obesity and
cardiovascular risk diseases with aging in Chinese adults. Sci Rep.
8(5806)2018.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Lu Y, Li SX, Liu Y, Rodriguez F, Watson
KE, Dreyer RP, Khera R, Murugiah K, D'Onofrio G, Spatz ES, et al:
Sex-specific risk factors associated with first acute myocardial
infarction in young adults. JAMA Netw Open.
5(e229953)2022.PubMed/NCBI View Article : Google Scholar
|
|
35
|
DeFilippis EM, Collins BL, Singh A, Biery
DW, Fatima A, Qamar A, Berman AN, Gupta A, Cawley M, Wood MJ, et
al: Women who experience a myocardial infarction at a young age
have worse outcomes compared with men: The Mass General Brigham
YOUNG-MI registry. Eur Heart J. 41:4127–4137. 2020.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Cole JH, Miller JI III, Sperling LS and
Weintraub WS: Long-term follow-up of coronary artery disease
presenting in young adults. J Am Coll Cardiol. 41:521–528.
2003.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Shi Q, Wang R, Zhang H, Shan Y, Ye M and
Jia B: Association between serum uric acid and cardiovascular
disease risk factors in adolescents in America: 2001-2018. PLoS
One. 16(e0254590)2021.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Liu L, Zhao T, Shan L, Cao L, Zhu X and
Xue Y: Estradiol regulates intestinal ABCG2 to promote urate
excretion via the PI3K/Akt pathway. Nutr Metab (Lond).
18(63)2021.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Ioannou GN and Boyko EJ: Effects of
menopause and hormone replacement therapy on the associations of
hyperuricemia with mortality. Atherosclerosis. 226:220–227.
2013.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Nunes PR, Romao-Veiga M, Peracoli MTS,
Peracoli JC and Sandrim VC: Potential role of uric acid to activate
NLRP3 inflammasome triggering endothelial dysfunction in
preeclampsia. Clin Immun Commun. 2:69–75. 2022.
|
|
41
|
Cao D, Pu H, Yuan X, Li Z, Yu X and Shi X:
The interplay between NLRP3 inflammasome and metabolic signals in
gouty arthritis. Front Immunol. 17(1761121)2026.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Dogru S, Yasar E and Yesilkaya A: Effects
of uric acid on oxidative stress in vascular smooth muscle cells.
Biomed Rep. 21(171)2024.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Gherghina ME, Peride I, Tiglis M, Neagu
TP, Niculae A and Checherita IA: Uric acid and oxidative
stress-relationship with cardiovascular, metabolic, and renal
impairment. Int J Mol Sci. 23(3188)2022.PubMed/NCBI View Article : Google Scholar
|
|
44
|
McMillen RC, Gottlieb MA, Shaefer RMW,
Winickoff JP and Klein JD: trends in electronic cigarette use among
U.S. adults: Use is increasing in both smokers and nonsmokers.
Nicotine Tob Res. 17:1195–1202. 2015.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Vikulova DN, Trinder M, Mancini GBJ,
Pimstone SN and Brunham LR: Familial hypercholesterolemia, familial
combined hyperlipidemia, and elevated lipoprotein(a) in patients
with premature coronary artery disease. Can J Cardiol.
37:1733–1742. 2021.PubMed/NCBI View Article : Google Scholar
|
|
46
|
Aminbakhsh AP, Théberge ET, Burden E,
Adejumo CK, Gravely AK, Lehman A and Sedlak TL: Exploring
associations between estrogen and gene candidates identified by
coronary artery disease genome-wide association studies. Front
Cardiovasc Med. 12(1502985)2025.PubMed/NCBI View Article : Google Scholar
|
|
47
|
Knowlton AA and Lee AR: Estrogen and the
cardiovascular system. Pharmacol Ther. 135:54–70. 2012.PubMed/NCBI View Article : Google Scholar
|
|
48
|
Fuentes N and Silveyra P: Chapter
Three-Estrogen receptor signaling mechanisms. In: Donev R (ed).
Advances in Protein Chemistry and Structural Biology. Vol. 116.
Academic Press, Elsevier, pp135-170, 2019.
|
|
49
|
Strong A and Rader DJ: Sortilin as a
regulator of lipoprotein metabolism. Curr Atheroscler Rep.
14:211–218. 2012.PubMed/NCBI View Article : Google Scholar
|
|
50
|
Karabay G, Bayraktar B, Seyhanli Z, Cakir
BT, Aktemur G, Sucu ST, Tonyali NV, Karabay U, Kurt D and Caglar
AT: Evaluating maternal serum sortilin levels: A potential
biomarker for predicting preeclampsia. BMC Pregnancy Childbirth.
25(338)2025.PubMed/NCBI View Article : Google Scholar
|
|
51
|
Çalışkan Burgucu H, Yarar Z, Can M,
Karadeniz Y, Yerlikaya Aydemir FH, Karaköse M, Kulaksızoğlu M and
Karakurt F: CIMT as a sensitive indicator of cardiovascular risk in
PCOS: A case-control study of sortilin and sclerostin. BMC Womens
Health. 26(163)2026.PubMed/NCBI View Article : Google Scholar
|
|
52
|
Alarslan P and Doruk M: Serum sortilin
levels as a biomarker for metabolic and hormonal dysregulation in
polycystic ovary syndrome. J Pers Med. 15(70)2025.PubMed/NCBI View Article : Google Scholar
|
|
53
|
Chu X, Liu R, Li C, Gao T, Dong Y, Jiang Y
and Ke D: The association of plasma sortilin with essential
hypertension and subclinical carotid atherosclerosis: A
cross-sectional study. Front Cardiovasc Med.
9(966890)2022.PubMed/NCBI View Article : Google Scholar
|
|
54
|
Kjolby M, Andersen OM, Breiderhoff T,
Fjorback AW, Pedersen KM, Madsen P, Jansen P, Heeren J, Willnow TE
and Nykjaer A: Sort1, encoded by the cardiovascular risk locus
1p13.3, is a regulator of hepatic lipoprotein export. Cell Metab.
12:213–223. 2010.PubMed/NCBI View Article : Google Scholar
|
|
55
|
Kathiresan S, Melander O, Guiducci C,
Surti A, Burtt NP, Rieder MJ, Cooper GM, Roos C, Voight BF,
Havulinna AS, et al: Six new loci associated with blood low-density
lipoprotein cholesterol, high-density lipoprotein cholesterol or
triglycerides in humans. Nat Genet. 40:189–197. 2008.PubMed/NCBI View Article : Google Scholar
|
|
56
|
Musunuru K, Strong A, Frank-Kamenetsky M,
Lee NE, Ahfeldt T, Sachs KV, Li X, Li H, Kuperwasser N, Ruda VM, et
al: From noncoding variant to phenotype via SORT1 at the 1p13
cholesterol locus. Nature. 466:714–719. 2010.PubMed/NCBI View Article : Google Scholar
|
|
57
|
Teslovich TM, Musunuru K, Smith AV,
Edmondson AC, Stylianou IM, Koseki M, Pirruccello JP, Ripatti S,
Chasman DI, Willer CJ, et al: Biological, clinical and population
relevance of 95 loci for blood lipids. Nature. 466:707–713.
2010.PubMed/NCBI View Article : Google Scholar
|
|
58
|
Samani NJ, Erdmann J, Hall AS,
Hengstenberg C, Mangino M, Mayer B, Dixon RJ, Meitinger T, Braund
P, Wichmann HE, et al: Genomewide association analysis of coronary
artery disease. N Engl J Med. 357:443–453. 2007.PubMed/NCBI View Article : Google Scholar
|
|
59
|
Siri-Tarino PW, Williams PT, Fernstrom HS,
Rawlings RS and Krauss RM: Reversal of small, dense LDL subclass
phenotype by normalization of adiposity. Obesity (Silver Spring).
17:1768–1775. 2009.PubMed/NCBI View Article : Google Scholar
|
|
60
|
Elias N, Patterson BW and Schonfeld G:
Decreased production rates of VLDL triglycerides and ApoB-100 in
subjects heterozygous for familial hypobetalipoproteinemia.
Arterioscler Thromb Vasc Biol. 19:2714–2721. 1999.PubMed/NCBI View Article : Google Scholar
|
|
61
|
De Castro-Orós I, Pocoví M and Civeira F:
The genetic basis of familial hypercholesterolemia: Inheritance,
linkage, and mutations. Appl Clin Genet. 3:53–64. 2010.PubMed/NCBI View Article : Google Scholar
|
|
62
|
Strong A, Ding Q, Edmondson AC, Millar JS,
Sachs KV, Li X, Kumaravel A, Wang MY, Ai D, Guo L, et al: Hepatic
sortilin regulates both apolipoprotein B secretion and LDL
catabolism. J Clin Invest. 122:2807–2816. 2012.PubMed/NCBI View Article : Google Scholar
|
|
63
|
Goettsch C, Hutcheson JD, Aikawa M, Iwata
H, Pham T, Nykjaer A, Kjolby M, Rogers M, Michel T, Shibasaki M, et
al: Sortilin mediates vascular calcification via its recruitment
into extracellular vesicles. J Clin Invest. 126:1323–1336.
2016.PubMed/NCBI View Article : Google Scholar
|
|
64
|
Thomas MJ and Sorci-Thomas MG: Linking
lipid-related transcription and cardiovascular disease through
GWAS. Circ Res. 127:1362–1364. 2020.PubMed/NCBI View Article : Google Scholar
|
|
65
|
Sun S, Yang J, Xie W, Peng T and Lv Y:
Complicated trafficking behaviors involved in paradoxical
regulation of sortilin in lipid metabolism. J Cell Physiol.
235:3258–3269. 2020.PubMed/NCBI View Article : Google Scholar
|
|
66
|
Meraş İ, Maes J and Lefrancois S:
Mechanisms regulating the sorting of soluble lysosomal proteins.
Biosci Rep. 42(BSR20211856)2022.PubMed/NCBI View Article : Google Scholar
|
|
67
|
Conlon DM, Schneider CV, Ko YA, Rodrigues
A, Guo K, Hand NJ and Rader DJ: Sortilin restricts secretion of
apolipoprotein B-100 by hepatocytes under stressed but not basal
conditions. J Clin Invest. 132(e144334)2022.PubMed/NCBI View Article : Google Scholar
|
|
68
|
Shapiro MD, Tavori H and Fazio S: PCSK9:
From basic science discoveries to clinical trials. Circ Res.
122:1420–1438. 2018.PubMed/NCBI View Article : Google Scholar
|
|
69
|
Patel KM, Strong A, Tohyama J, Jin X,
Morales CR, Billheimer J, Millar J, Kruth H and Rader DJ:
Macrophage sortilin promotes LDL uptake, foam cell formation, and
atherosclerosis. Circ Res. 116:789–796. 2015.PubMed/NCBI View Article : Google Scholar
|
|
70
|
Jansen IL, Șahin D, Gijsen FJH, Farrell E
and van der Heiden K: Investigating the impact of
microcalcification size and volume on collagenous matrix and tissue
mechanics using a tissue-engineered atherosclerotic cap model.
Front Cardiovasc Med. 12(1629285)2025.PubMed/NCBI View Article : Google Scholar
|
|
71
|
Mortensen MB, Kjolby M, Gunnersen S,
Larsen JV, Palmfeldt J, Falk E, Nykjaer A and Bentzon JF: Targeting
sortilin in immune cells reduces proinflammatory cytokines and
atherosclerosis. J Clin Invest. 124:5317–5322. 2014.PubMed/NCBI View Article : Google Scholar
|
|
72
|
Jansen I, Cahalane R, Hengst R, Akyildiz
A, Farrell E, Gijsen F, Aikawa E, van der Heiden K and Wissing T:
The interplay of collagen, macrophages, and microcalcification in
atherosclerotic plaque cap rupture mechanics. Basic Res Cardiol.
119:193–213. 2024.PubMed/NCBI View Article : Google Scholar
|
|
73
|
Corti A, De Paolis A, Grossman P, Dinh PA,
Aikawa E, Weinbaum S and Cardoso L: The effect of plaque
morphology, material composition and microcalcifications on the
risk of cap rupture: A structural analysis of vulnerable
atherosclerotic plaques. Front Cardiovasc Med.
9(1019917)2022.PubMed/NCBI View Article : Google Scholar
|
|
74
|
Ogura M, Ayaori M, Terao Y, Hisada T,
Iizuka M, Takiguchi S, Uto-Kondo H, Yakushiji E, Nakaya K, Sasaki
M, et al: Proteasomal inhibition promotes ATP-binding cassette
transporter A1 (ABCA1) and ABCG1 expression and cholesterol efflux
from macrophages in vitro and in vivo. Arterioscler Thromb Vasc
Biol. 31:1980–1987. 2011.PubMed/NCBI View Article : Google Scholar
|
|
75
|
Sigaeva A, Hutchings C, Cesnik A, Lilley
KS and Lundberg E: Subcellular localization as a driver of protein
function. Nat Rev Mol Cell Biol. 27:493–510. 2026.PubMed/NCBI View Article : Google Scholar
|
|
76
|
Marian AJ: Genome-wide association studies
complemented with mechanistic biological studies identify sortilin
1 as a novel regulator of cholesterol trafficking. Curr Atheroscler
Rep. 13:190–192. 2011.PubMed/NCBI View Article : Google Scholar
|
|
77
|
Yang M, Ge J, Liu YL, Wang HY, Wang ZH, Li
DP, He R, Xie YY, Deng HY, Peng XM, et al: Sortilin-mediated
translocation of mitochondrial ACSL1 impairs adipocyte
thermogenesis and energy expenditure in male mice. Nat Commun.
15(7746)2024.PubMed/NCBI View Article : Google Scholar
|
|
78
|
Hivelin C, Mazella J and Coppola T:
Sortilin derived propeptide regulation during adipocyte
differentiation and inflammation. Biochem Biophys Res Commun.
482:87–92. 2017.PubMed/NCBI View Article : Google Scholar
|
|
79
|
Shi J and Kandror KV: Sortilin is
essential and sufficient for the formation of Glut4 storage
vesicles in 3T3-L1 adipocytes. Dev Cell. 9:99–108. 2005.PubMed/NCBI View Article : Google Scholar
|
|
80
|
Canuel M, Libin Y and Morales CR: The
interactomics of sortilin: An ancient lysosomal receptor evolving
new functions. Histol Histopathol. 24:481–492. 2009.PubMed/NCBI View Article : Google Scholar
|
|
81
|
Sokolowska E and Blachnio-Zabielska A: The
role of ceramides in insulin resistance. Front Endocrinol
(Lausanne). 10(577)2019.PubMed/NCBI View Article : Google Scholar
|
|
82
|
Ertaş S, Ünver G, Gonca Okumuş Z, Yılmaz
S, Dağ İ and Turhan U: Maternal serum sortilin-1 level as a
potential biomarker for intrahepatic cholestasis of pregnancy.
Gynecol Endocrinol. 38:935–938. 2022.PubMed/NCBI View Article : Google Scholar
|
|
83
|
Lv Y, Yang J, Gao A, Sun S, Zheng X, Chen
X, Wan W, Tang C, Xie W, Li S, et al: Sortilin promotes macrophage
cholesterol accumulation and aortic atherosclerosis through
lysosomal degradation of ATP-binding cassette transporter A1
protein. Acta Biochim Biophys Sin (Shanghai). 51:471–483.
2019.PubMed/NCBI View Article : Google Scholar
|
|
84
|
Yao Y, Li S and Wang S: The role of
sortilin in cardiovascular calcification: Mechanisms and
therapeutic potential. Front Cardiovasc Med.
13(1805742)2026.PubMed/NCBI View Article : Google Scholar
|
|
85
|
Goettsch C, Kjolby M and Aikawa E:
Sortilin and its multiple roles in cardiovascular and metabolic
diseases. Arterioscler Thromb Vasc Biol. 38:19–25. 2018.PubMed/NCBI View Article : Google Scholar
|
|
86
|
Mosca L, Grundy SM, Judelson D, King K,
Limacher M, Oparil S, Pasternak R, Pearson TA, Redberg RF, Smith SC
Jr, et al: Guide to preventive cardiology for women.AHA/ACC
scientific statement consensus panel statement. Circulation.
99:2480–2484. 1999.PubMed/NCBI View Article : Google Scholar
|
|
87
|
Oh TJ, Ahn CH, Kim BR, Kim KM, Moon JH,
Lim S, Park KS, Lim C, Jang H and Choi SH: Circulating sortilin
level as a potential biomarker for coronary atherosclerosis and
diabetes mellitus. Cardiovasc Diabetol. 16(92)2017.PubMed/NCBI View Article : Google Scholar
|
|
88
|
Werida RH, Omran A and El-Khodary NM:
Sortilin and homocysteine as potential biomarkers for coronary
artery diseases. Int J Gen Med. 14:6167–6176. 2021.PubMed/NCBI View Article : Google Scholar
|
|
89
|
Hu D, Yang Y and Peng DQ: Increased
sortilin and its independent effect on circulating proprotein
convertase subtilisin/kexin type 9 (PCSK9) in statin-naive patients
with coronary artery disease. Int J Cardiol. 227:61–65.
2017.PubMed/NCBI View Article : Google Scholar
|
|
90
|
Møller PL, Rohde PD, Winther S, Breining
P, Nissen L, Nykjaer A, Bøttcher M, Nyegaard M and Kjolby M:
Sortilin as a biomarker for cardiovascular disease revisited. Front
Cardiovasc Med. 8(652584)2021.PubMed/NCBI View Article : Google Scholar
|
|
91
|
Budda B, Mitra A, Park L, Long H,
Kurnellas M, Bien-Ly N, Estacio W, Burgess B, Chao G, Schwabe T, et
al: Development of AL101 (GSK4527226), a progranulin-elevating
monoclonal antibody, as a potential treatment for Alzheimer's
disease. Alzheimers Res Ther. 17(174)2025.PubMed/NCBI View Article : Google Scholar
|
|
92
|
Ghaemimanesh F, Bayat AA, Babaei S,
Ahmadian G, Zarnani AH, Behmanesh M, Jeddi-Tehrani M and Rabbani H:
Production and characterization of a novel monoclonal antibody
against human sortilin. Monoclon Antib Immunodiagn Immunother.
34:390–395. 2015.PubMed/NCBI View Article : Google Scholar
|
|
93
|
Quistgaard EM, Grøftehauge MK, Madsen P,
Pallesen LT, Christensen B, Sørensen ES, Nissen P, Petersen CM and
Thirup SS: Revisiting the structure of the Vps10 domain of human
sortilin and its interaction with neurotensin. Protein Sci.
23:1291–1300. 2014.PubMed/NCBI View Article : Google Scholar
|
|
94
|
Malong L, Roskosch J, Hager C, Fortin JP,
Schmucki R, Callow MG, Weile C, Romeo V, Patsch C, Martin S, et al:
A CRISPR/Cas9 screen reveals proteins at the endosome-Golgi
interface that modulate cellular anti-sense oligonucleotide
activity. Nat Commun. 16(5378)2025.PubMed/NCBI View Article : Google Scholar
|
|
95
|
Lupieri A, Becker-Greene D, Le TD, Roschel
MM, Jha PK, Sonawane AR, Mullick A, Tsimikas S, Kuraoka S, Singh
SA, et al: Antisense oligonucleotide targeting sortilin reduces
vascular calcification in mice in a sex-dependent manner.
Arterioscler Thromb Vasc Biol. 45:1398–1415. 2025.PubMed/NCBI View Article : Google Scholar
|
|
96
|
Debacker AJ, Voutila J, Catley M, Blakey D
and Habib N: Delivery of oligonucleotides to the liver with GalNAc:
From research to registered therapeutic drug. Mol Ther.
28:1759–1771. 2020.PubMed/NCBI View Article : Google Scholar
|
|
97
|
Wang X, Raghavan A, Peters DT, Pashos EE,
Rader DJ and Musunuru K: Interrogation of the
atherosclerosis-associated SORT1 (sortilin 1) locus with primary
human hepatocytes, induced pluripotent stem cell-hepatocytes, and
locus-humanized mice. Arterioscler Thromb Vasc Biol. 38:76–82.
2018.PubMed/NCBI View Article : Google Scholar
|
|
98
|
Schrøder TJ, Christensen S, Lindberg S,
Langgård M, David L, Maltas PJ, Eskildsen J, Jacobsen J, Tagmose L,
Simonsen KB, et al: The identification of AF38469: An orally
bioavailable inhibitor of the VPS10P family sorting receptor
sortilin. Bioorg Med Chem Lett. 24:177–180. 2014.PubMed/NCBI View Article : Google Scholar
|
|
99
|
Almoyad MAA, Wahab S, Mohanto S and Khan
NJ: Repurposing drugs to modulate sortilin: Structure-guided
strategies against atherogenesis, coronary artery disease, and
neurological disorders. ACS Omega. 9:18438–18448. 2024.PubMed/NCBI View Article : Google Scholar
|
|
100
|
Lionta E, Spyrou G, Vassilatis D and
Cournia Z: Structure-based virtual screening for drug discovery:
Principles, applications and recent advances. Curr Top Med Chem.
14:1923–1938. 2014.PubMed/NCBI View Article : Google Scholar
|
|
101
|
Larsen JV, Hansen M, Møller B, Madsen P,
Scheller J, Nielsen M and Petersen CM: Sortilin facilitates
signaling of ciliary neurotrophic factor and related helical type 1
cytokines targeting the gp130/leukemia inhibitory factor receptor β
heterodimer. Mol Cell Biol. 30:4175–4187. 2010.PubMed/NCBI View Article : Google Scholar
|
|
102
|
Ogawa K, Ueno T, Iwasaki T, Kujiraoka T,
Ishihara M, Kunimoto S, Takayama T, Kanai T, Hirayama A and Hattori
H: Soluble sortilin is released by activated platelets and its
circulating levels are associated with cardiovascular risk factors.
Atherosclerosis. 249:110–115. 2016.PubMed/NCBI View Article : Google Scholar
|
|
103
|
Linsel-Nitschke P, Heeren J, Aherrahrou Z,
Bruse P, Gieger C, Illig T, Prokisch H, Heim K, Doering A, Peters
A, et al: Genetic variation at chromosome 1p13.3 affects sortilin
mRNA expression, cellular LDL-uptake and serum LDL levels which
translates to the risk of coronary artery disease. Atherosclerosis.
208:183–189. 2010.PubMed/NCBI View Article : Google Scholar
|
|
104
|
Guo J, Luo YX, Tao LX and Guo XH:
Association between 1p13.3 genomic markers and coronary artery
disease: A meta-analysis involving patients and controls. Genet Mol
Res. 14:9092–9102. 2015.PubMed/NCBI View Article : Google Scholar
|
